AzTrials
AzTrials

Colon SurgeryNCT05981937

ICG Anastomosis Control in Colon Surgery

An observational study of Colon Surgery and Anastomotic Leak, run by Azienda Unita Sanitaria Locale di Piacenza at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Colon Surgery, Anastomotic Leak
What is being tested?
ICG solution
Type of treatment
Injection or infusion
How many people
115 participants
Where
1 siteItaly
Study dates
20 Jul 2023to 1 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: A consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023

Who may be able to join

  • elective setting of surgery
  • segmentary left colon surgery including transverse resection, splenic flexure resection and left colectomy even for benign or malign pathology
  • 30 days of post-operative follow-up at least available from medical documentation
  • primary colo-colic or colo-rectal anastomosis with or without preventing ostomy
  • more than 18 years old, less than 90 years old

Who cannot join

  • terminal colonic stoma without anastomosis creation after demolitive step
  • extended transverse right hemicolectomy
  • left hemicolectomy with high vascular ligation
  • associated bowel or another splanchnic resection (i.e. neoplastic infiltration)
  • previous colic surgery
  • synchronous neoplasm
Show all 12Show fewer
  • not reporting in operating form details about vascular ligation
  • lack in reporting in medical records of primary outcomes
  • stage IV cancer
  • ASA IV
  • less than 18 years old, more then 90 years old
  • emergency setting

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Guglielmo da Saliceto Hospital

    Piacenza, 29121

Other trials in Italy

About this study

Official title: Indocyanine Green ICG in Segmentary Resection in Colo-rectal Surgery is Usefull to Decrease Leak Threshold: A Paralel Retrospetive Cohort Study

This is a parallel monocentric, retrospective cohort study in Guglielmo da Saliceto Hospital, Piacenza, Italy. Aim of this study is to investigate the protective role of Indocyanine green (ICG) for Anastomotic leak (AL) in patients underwent elective segmentary colic resection (transverse colic resection, left colectomy including sigmoidectomy, splenic colic flexure resection). Secondary aims are to detect and to investigate the impact of various risk factors on AL and morbidity and surgical performance within 30 days to surgery.

Read the detailed description

This is a parallel monocentric, retrospective cohort study observing consecutive series of patients underwent colo-rectal surgery at our institution between 1 January 2017 and 31 July 2023.

The primary endpoint of the study is Anastomotic Leak (AL) at 30 days while secondary endpoints are post-operative morbidity Clavien-Dindo score ≥III within 30 days from surgery including readmission and redo-surgery, harvested nodes for patients with neoplastic disease, Surgical Site Infection, rate of laparoscopic surgical procedure and rate of protection stoma.

Sex, Body Mass Index, smoking, diabetes mellitus, cardiovascular disease, tumor stage according to AJJC 8th edition will be considered confounding factor for onset of AL.

Patients electronic database will be collected from extraction of medical record in operating log and every digital medical record will be scanned including peri-operative outcomes and 30 days post-operative follow-up from post-operative visit, eventually readmission in emergency department or any other specialistic wards of our local health institution according to following inclusion criteria: elective setting of surgery, segmentary left colon surgery: splenic colic resection, transverse colic resection and left colectomy defined as left hemicolectomy with low mesenteric artery-ligation and sigmoidectomy even for benign or malign pathology, at least 30 days of post-operative follow-up available from medical documentation, primary colo-colic or colo-rectal anastomosis with or without preventing ostomy and adult age.

Exclusion criteria are terminal colonic stoma without anastomosis creation after demolitive step, extended transverse right hemicolectomy, left hemicolectomy with high vascular ligation, associated bowel or another splanchnic resection (i.e. neoplastic infiltration), previous colic surgery, synchronous neoplasm, not reporting in operating form details about vascular ligation, lack in reporting in medical records of primary outcomes, stage IV cancer, ASA IV, less than 18 years old and emergency setting.

The reconstruction time is performed with different anastomosis (colo-colic or colo-rectal), technique (stapler or hand sewn) and connection (side to side, side to end, end to side or end to end).

ICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction).

Statistical analysis and sample size:

Quantitative variables will be described by mean± standard deviation or median and IQR, and qualitative variables will be described by absolute and percentage frequencies. Normality will be checked for all continuous variables. Comparisons of covariates will be conducted using Pearson's X2 test or Fisher's exact test for categorical variables and a t-test or Mann Whitney test for continuous variables. Univariable analysis will be conducted using logistic regression to examine the association of each predictor variable with the anastomotic leakage event. Next, variables with p<0.1 will be considered for inclusion in a multivariable regression model. For each risk factor, odds ratio with associated confidence intervals will have been presented. All analyses will be performed using RStudio version 3.6.0 statistical software with two-side significance tests and a 5% significance level.

Being tested
ICG solution
Keywords
ICG, Colon Surgery, Anastomotic Leak
Medical subject headings
Anastomotic Leak

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ICG solutionDrug

    Also called Indocyanine Green

    ICG-ATT is available at our institute since 2019 using a near-infrared (NIR) light source and special scope and camera equipped with xenon light (CARL STORZ GmbH \& Co. KG, Tuttlingen, Germany); ICG was supplied as a sterile water-soluble lyophilized powder (Diagnostic Green® GmbH). ICG-ATT is routinely used whenever available in daily practice with the following protocol: after the specimen resection the two colonic stumps or colonic and rectal stumps are checked with 5 cc of ICG 25 mg diluted in 10 cc of water sterile solution before fashioned anastomosis. Two laparoscopes with ICG-optic system are nowadays available department and ICG anastomosis control is always performed if ICG device are available (no performed in case of not available ICG instrument for sterilization in case of two consecutive surgery in the same day, concomitant ICG surgery or ICG malfunction).

Study groups in NCT05981937
Study groupRoleWhat they receive
Indocyanine GreenIndocyanine green infusion in left-side colorectal surgery (elective segmentary colic resection)
Receives: Drug: ICG solution
non-Indocyanine GreenNo infusion of Indocyanine green in left-side colorectal surgery (elective segmentary colic resection )

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anastomotic leak at 30 days

    Anastomotic leak (a defect of intestinal wall at anastomotic site leading to a communication between the intra- and extraluminal compartments)at 30 days: abdominal CT scan IV and a Clavien Dindo Score ≥III

    Measured: 30 days

Secondary outcomes (1)
  1. Post-operative morbidity

    Clavien-Dindo score ≥III within 30 days from surgery including readmission and redo-surgery, harvested nodes for patients with neoplastic disease, Surgical Site Infection, rate of laparoscopic surgical procedure and rate of protection stoma.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2023
  2. Study start20 Jul 2023
  3. Primary completion1 Dec 2023
  4. Study completion1 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
115 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05981937
Sponsor's protocol ID
GREEN COLONIC SAFE ANASTOMOSIS
Status last verified
Mar 2024
First submitted
1 Aug 2023
Last updated
18 Mar 2024
Results posted
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No

Publications

  • Romboli A, Orlandi E, Citterio C, Banchini F, Ribolla M, Palmieri G, Giuffrida M, Luzietti E, Capelli P. Indocyanine green in left side colorectal surgery segmental resection to decrease anastomotic leak: A parallel retrospective cohort study of 115 patients. Heliyon. 2024 Oct 24;10(23):e39730. doi: 10.1016/j.heliyon.2024.e39730. eCollection 2024 Dec 15.

    PubMed 39687188

Questions about this trial

What is this clinical trial studying?

An observational study of Colon Surgery and Anastomotic Leak, run by Azienda Unita Sanitaria Locale di Piacenza at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anastomotic leak at 30 days (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05981937, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in